Apomorphine-induced penile tumescence in impotent patients - preliminary findings

Progress in Neuropsychopharmacology and Biological Psychiatry

Volumn 11, Issue 2-3, 1987, Pages 235-242

  Lal, Samarthji ^a,b   Laryea, Eric ^b   Thavundayil, Joseph X ^a   Nair, N P Vasavan ^a   Negrete, Juan ^b   Ackman, Douglas ^b   Blundell, Peter ^b   Gardiner, Robert J ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

apomorphine; bromocriptine; dopamine; impotence; penile erection

Indexed keywords

PRIORITY JOURNAL;

ADULT; APOMORPHINE; BROMOCRIPTINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PENILE ERECTION; PROGNOSIS; PROLACTIN;

EID: 0023186063     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/0278-5846(87)90066-2     Document Type: Article

References (43)

1. Study of the effects of bromocriptine on sexual impotence
2. Penile erection induced by apomorphine and N-n-propyl-norapomorphine in rats
3. Effect of L-dopa on sexually impotent patients
4. Pharaacotherapy of sexual impotence in the male
5. Improved sexual function in male haemodialysis patients on bromocriptine
6. Sexual behaviour during L-dopa treatment for Parkinsonism
7. Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence
8. Sexual function and effect in Parkinsonian men treated with L-dopa
9. La prolactinémie dans 845 cas de dysfunctions sexuelles cliniquement idiopathiques
10. Prolactin secreting tumours and hypogonadism in 22 men
11. Multidisciplinary survey of erectile impotence
12. Bromocriptine in impotence
13. Prevalence and presentation of hyperprolactinemia in patients with functional pituitary tumors
14. The yawningpenile erection syndrome as a model for putative dopamine autoreceptor activity
15. Association of spontaneous and dopaminergic-induced yawning and penile erections in the rat
16. The activating effect of L-dopa treatment on sexual functions and its experimental background
17. Nocturnal erections, differential diagnosis of impotence and diabetes
18. Clinical studies with apomorphine
19. Apomorphine and psychopathology
20. Effect of methysergide and pimozide on apoMorphine-induced growth hormone secretion in men
21. Effect of naloxone or levallorphan on serum prolactin concentrations and apomorphine-induced growth hormone secretion
22. Effect of domperidone on apomorphine-induced growth hormone secretion in normal men
23. Effect of apomorphine,.a dopamine receptor agonist, on penile tumescence in normal subjects
24. A psychoneuroendocrinological study of sexual Impotence in patients with abnormal reaction to a glucose tolerance test
25. Erectile Impotence: a clinical challenge
26. Nonhormonal pharmacological treatment of organic Impotence
27. Effect of sulplrlde, an atypical neuroleptic, on apomorphine-induced growth hormone secretion
28. Mental effects of high dosage levodopa
29. Male erectile disorders
30. Treatment of alcoholism using Dent's oral apomorphine method
31. Treatment of alcoholics with apomorphine using Dent's method: a preliminary study
32. Hypersexuality complicating levodopa (L-Dopa) therapy
33. Impotence in medical clinical outpatients
34. Apomorphine and its relation to dopamine in the nervous system
35. Impotence is not always psychogenic. Newer Insights Into hypothalamlc-pituitary-gonadal dysfunction
36. Impotence from a psychiatric standpoint
37. Time-course of apomorphine in the brain of the immature rat after apomorphine injection
38. Long-term treatment of galactorrhoea and hypogonadism with bromocriptine
39. Effect of monoamine receptor agonists and antagonists on cyclic AMP accumulation in human cerebral cortex slices
40. Hypersexuality — a complication of dopaminergic therapy in Parkinson's disease
41. Impotence